EP Patent

EP2765988B1 — Ocular composition containing bromfenac with increased bioavailability

Assigned to Bausch and Lomb Inc · Expires 2024-09-18 · 2y expired

What this patent protects

Patent listed against bromfenac-sodium.

Drugs covered by this patent

bromfenac-sodium (BROMFENAC SODIUM)

Patent Metadata

Patent number: EP2765988B1
Jurisdiction: EP
Classification: —
Expires: 2024-09-18
Drug substance claim: No
Drug product claim: No
Assignee: Bausch and Lomb Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.